Synthetic Controls (cfDNA Pan-Cancer)

About Twist Bioscience

Twist Bioscience leverages its proprietary silicon-based DNA synthesis platform to manufacture high-quality, precise synthetic DNA at scale, enabling innovation across diverse fields. The company has expanded from core gene synthesis into high-growth markets like next-generation sequencing (NGS), antibody discovery, and synthetic biology tools. As a publicly traded company, Twist aims to be the foundational platform for the bioeconomy, supporting customers in accelerating research and development timelines.

Therapeutic Areas